REFERENCES
1. Ziegelbauer K, Light DR. Monoclonal antibody therapeutics: Leading companies to maximise sales and market share. J Commer Biotechnol. 2008;14:65–72.
2. Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC. Monoclonal antibody successes in the clinic. Nat Biotechnol. 2005;23:1073–78.
3. International Conference on Harmonization. Q6B, Specifications: test procedures and acceptance criteria for biotechnological/biological products. Geneva, Switzerland; 1999.
4. US Food and Drug Administration. Guidance for industry. Points to consider in the manufacture and testing of monoclonal antibody products for human use. Rockville, MD; 1997.
5. Schnerman MA, Sunday BR, Kozlowski S, Webber K, Gazzano-Santoro H, Mire-Sluis A. CMC strategy forum report: analysis and structure characterization of monoclonal antibodies. BioProcess Int. 2004;2:42–52.
6. Swann PG, Tolnay M, Muthukkumar S, Shapiro MA, Rellahan BL, Clouse KA. Considerations for the development of therapeutic monoclonal antibodies. Curr Opin Immunol. 2008;42:493–99.
7. Shapiro MA, Swann PG, Hartsough M. Regulatory considerations in the development of monoclonal antibodies for diagnosis and therapy. In: Dubel S, editor. Handbook of Therapeutic Antibodies. Weinham, Germany: Wiley VCH; 2005.
8. Kozlowski S, Swann P. Considerations for biotechnology product Quality by Design. Rathore AS, Mhatre R, editors. In: Quality by Design for biopharmaceuticals: Perspectives and case studies. New Jersey. Wiley Interscience. 2009;9–30.
9. Chirino AJ, Mire-Sluis A. Characterizing biological products and assessing comparability following manufacturing changes. Nat Biotechnol. 2004;22:1383–91.
10. United States Pharmacopeia: USP/NF General Chapter 125. United States Pharmacopeial Convention. Rockville, MD. 2008.
11. US FDA. Guidance for industry. Validation of chromatographic methods. Rockville, MD; 1994.
12. US FDA. Guidance for industry. Bioanalytical method validation for human studies. Rockville, MD; 1998.
13. Bakshi M, Singh S. Development of validated stability-indicating assay methods—critical review. J Pharm Biomed Anal. 2002;28:1011–40.
14. ICH. Q2(R1), Validation of analytical procedures: text and methodology. Geneva, Switzerland; 2005.
15. Flatman S, Alam I, Gerard J, Mussa N. Process analytics for purification of monoclonal antibodies. J Chromatogr B. 2007;848:79–87.
16. Farnan D, Moreno GT. Multi-product high-resolution monoclonal antibody charge variant separations by pH gradient ion-exchange chromatography. Anal Chem. 2009;81:8846–57.
17. Salas-Solano O, Gennaro L, Felten C. Optimization approaches in the routine analysis of monoclonal antibodies by capillary electrophoresis. LC-GC Europe. 2008;12:615–22.
18. Krull IS, Liu X, Dai J, Gendreau C, Li G. HPCE methods for the identification and quantitation of antibodies, their conjugates and complexes. J Pharm Biomed Anal. 1997;16:377–93.
19. Hunt G, Nashabeh W. Capillary electrophoresis sodium dodecyl sulfate nongel sieving analysis of a therapeutic recombinant monoclonal antibody: a biotechnology perspective. Anal Chem. 1999;71:2390–97.
20. Ma S. Analysis of protein therapeutics by capillary electrophoresis: applications and challenges. In: Mire-Sluis AR, editor. State of the Art Analytical Methods for the Characterization of Biological Products and Assessment of Comparability. Basel: Karger; 2005. p. 49–68.
21. Salas-Solano O, Tomlinson B, Du S, Parker M, Strahan A, Ma S. Optimization and validation of a quantitative capillary electrophoresis sodium dodecyl sulfate method for quality control and stability monitoring of monoclonal antibodies. Anal Chem. 2006;78:6583–94.
22. Sosic A, Houde D, Blum A, Carlage T, Lyubarskaya Y. Application of imaging capillary IEF for characterization and quantitative analysis of recombinant protein charge heterogeneity. Electrophoresis. 2008;29:4368–76.
23. Vasilyeva E, Woodard J, Taylor FR, Kretschmer M, Fajardo H, Lyubarskaya Y, Kobayashi K, Dingley A, Mhatre R. Development of a chip-based capillary gel electrophoresis method for quantification of a half-antibody in immunoglobulin G4 samples. Electrophoresis. 2004;25:3890–96.
24. Gaspar A, Englmann M, Fekete A, Harir M, Schmitt-Kopplin P. Trends in CE-MS 2005–2006. Electrophoresis. 2008;29:66–79.
25. Rea JC, Moreno GT, Lou Y, Farnan D. Validation of a pH gradient-based ion-exchange chromatography method for high-resolution monoclonal antibody charge variant separations. J Pharm Biomed Anal. 2010; doi: 10.1016/j.jpba.2010.08.30.
26. Rozhkova A. Quantitative analysis of monoclonal antibodies by cation-exchange chromatofocusing. J Chromatogr A. 2009;1216:5989–599.
27. Farnan D, Moreno GT, Stults J, Becker A, Tremintin G, van Gils M. Interlaced size exclusion liquid chromatography of monoclonal antibodies. J Chromatogr A. 2009;1216:8904–09.
28. Decrop W, Gendeh G, Swart R. Development of an automated method for monoclonal antibodies purification and analysis. Chromatogr Today. 2009;2:8–10.
29. Yang R, Farnan D, Chen N, Krawitz D, Ouyang J, Weikert S, Tang Y. 2-dimensional Protein A–size exclusion chromatography to evaluate cell line product titer and aggregate levels in harvested cell culture fluid. AAPS Annual Meeting. 2007.